Cefoselis - CAS 122841-10-5
Catalog number: 122841-10-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C19H22N8O6S2
Molecular Weight:
522.56
COA:
Inquire
Targets:
Antibacterial
Description:
Cefoselis, a new parenteral cephalosporin, was active against clinical isolates of both gram-positive and gram-negative aerobic bacteria. The activity of Cefoselis was similar to that of cefpirome and cefepime and generally superior to that of ceftazidime. Cefoselis showed potent antibacterial activity against Hemophilus influenzae and Moraxella catarrhalis.Cefoselis was highly active against MSSA and MSCNS. Cefoselis was poor in the activity against MRSA,MRCNS,PRSP and Enterococcus faecalis,and no activity for Enterococcus faecium.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Wincef
MSDS:
Inquire
1.Effect of experimental renal failure on the pharmacodynamics of cefoselis-induced seizures in rats.
Nagata M1, Yasuhara M. Biol Pharm Bull. 2001 Sep;24(9):1049-52.
We investigated the effect of infusion rate and experimental renal failure on the pharmacodynamics of cefoselis (CFSL)-induced seizures. As an animal model of CFSL-induced seizures, male Wistar rats received an intravenous infusion of CFSL at one of three different rates (1.4-5.8 g/h/rat) until the onset of maximal seizures (which occurred after 8.0 to 36.0 min of infusion). Samples of cerebrospinal fluid (CSF), blood (for serum), and brain were obtained immediately after stopping infusion of CSFL. The serum concentration of CFSL at the onset of seizures increased with increasing infusion rate, but brain and CSF concentrations of CFSL at the onset of seizures were not affected by the infusion rate. Ureter-ligated (UL) and control rats received an intravenous infusion of CFSL at 1.4 g/h/rat until the onset of seizures. Then the same procedure as used to determine the effect of infusion rate on the concentrations of CFSL was carried out. Renal failure was associated with a significant decrease in the amount of CFSL required to induce seizures.
2.Successful Treatment of Refractory Majocchi's Granuloma with Voriconazole and Review of Published Literature.
Liu HB1, Liu F, Kong QT, Shen YN, Lv GX, Liu WD, Sang H. Mycopathologia. 2015 Oct;180(3-4):237-43. doi: 10.1007/s11046-015-9902-5. Epub 2015 Jun 5.
Majocchi's granuloma (MG) is a rare deep skin dermatophyte infection that can occur either in immunocompetent or in immunocompromised individuals. Oral itraconazole or terbinafine is considered to be the first choice of treatment. We report an immunocompetent man with deep nodular form of MG, the form which is generally found in immunosuppressed individuals. Previous treatment with either oral itraconazole or terbinafine yielded no apparent improvement. After a series of examination, the man was diagnosed as having Trichophyton rubrum-induced MG mixed with bacterial infection as evidenced by growth of Klebsiella pneumoniae in tissue bacterial culture. The patient was treated with a combination of cefoselis and levofloxacin for bacterial clearance followed by voriconazole treatment. After approximately 4 months of voriconazole treatment, the lesions completely resolved. Alternative medicine (voriconazole) can be considered in case of refractory infections during MG treatment.
3.The beta-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABA(A) receptors.
Sugimoto M1, Fukami S, Kayakiri H, Yamazaki S, Matsuoka N, Uchida I, Mashimo T. Br J Pharmacol. 2002 Jan;135(2):427-32.
The action of the beta-lactam antibiotics, penicillin-G (PCG) and cefoselis (CFSL) on GABA(A) receptors (GABA(A)-R) was investigated using the two-electrode voltage clamp technique and Xenopus oocyte expressed murine GABA(A)-R. Murine GABA(A)-Rs were expressed in Xenopus oocytes by injecting cRNA that encoded for each subunit (alpha1, beta2, and gamma2) and the effects of PCG and CFSL on the alpha1beta2gamma2s subunit receptors were examined using two-electrode voltage clamp. Using the alpha1beta2gamma2s GABA(A)-R, PCG and CFSL inhibited GABA-induced currents in a concentration-dependent manner, with IC(50)s of 557.1+/-125.4 and 185.0+/-26.6 microM, respectively. The inhibitory action of PCG on GABA-induced currents was non-competitive whereas that of CFSL was competitive. Mutation of tyrosine to phenylalanine at position 256 in the beta2 subunit (beta2(Y256F)), which is reported to abolish the inhibitory effect of picrotoxin, drastically reduced the potency of PCG (IC(50)=28.
4.Stability studies of cefoselis sulfate in the solid state.
Zalewski P1, Skibiński R2, Talaczyńska A3, Paczkowska M3, Garbacki P3, Cielecka-Piontek J3. J Pharm Biomed Anal. 2015 Oct 10;114:222-6. doi: 10.1016/j.jpba.2015.05.033. Epub 2015 Jun 1.
The process of degradation was studied by using an HPLC-DAD method. Two degradation products were identified with a hybrid ESI-Q-TOF mass spectrometer. The influence of temperature and relative air humidity (RH) on the stability of cefoselis sulfate was investigated. In the solid state at increased RH the degradation of cefoselis sulfate was an autocatalytic reaction of the first order with respect to substrate concentration while in dry air was first-order reaction depending on the substrate concentration. The kinetic and thermodynamic parameters of degradation were calculated.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Antibacterial Products


CAS 19562-30-2 Piromidic acid

Piromidic acid
(CAS: 19562-30-2)

Piromidic acid is a quinolone antibiotic to treat gram-negative bacteria infections.

CAS 76801-85-9 Azathramycin

Azathramycin
(CAS: 76801-85-9)

Azithromycin, derived from erythromycin, is a antibiotic. It binds to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA. It is an...

CAS 515-64-0 Sulfisomidin

Sulfisomidin
(CAS: 515-64-0)

Sulfisomidin, closely related to sulfadimidine, is a sulfonamide antibacterial.

Relebactam
(CAS: 1174018-99-5)

Relebactam, a diazabicyclooctane derivatice, has wide spectrum inhibiting activity of β-lactamases. It has been stuied to be probably effective in the treatment...

CAS 82009-34-5 Cilastatin

Cilastatin
(CAS: 82009-34-5)

Cilastatin can prevent renal metabolism of penem and carbapenem antibiotics by specific and reversible dehydropeptidase I inhibition. It can be used as antibact...

CAS 62893-19-0 Cefoperazone

Cefoperazone
(CAS: 62893-19-0)

Cefoperazone is a cephalosporin antibiotic for inhibition of rMrp2-mediated [3H]E217βG uptake with IC50 of 199 μM.

Oritavancin diphosphate
(CAS: 192564-14-0)

Oritavancin, also known as LY333328, is a novel semisynthetic glycopeptide antibiotics.Oritavancin possesses potent and rapid bactericidal activity in vitro aga...

CAS 113981-44-5 Cefozopran hydrochloride

Cefozopran hydrochloride
(CAS: 113981-44-5)

Cefozopran HCl is a fourth-generation cephalosporin.

CAS 37091-65-9 Azlocillin sodium salt

Azlocillin sodium salt
(CAS: 37091-65-9)

Azlocillin is an acylampicillin antibiotic with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin is simila...

CAS 115551-26-3 Marbofloxacin hydrochloride

Marbofloxacin hydrochloride
(CAS: 115551-26-3)

Marbofloxacin hydrochloride is a potent antibiotic by inhibiting DNA-gyrase.

CAS 157542-49-9 CS-834

CS-834
(CAS: 157542-49-9)

CS-834, a carbapenem derivative, has been found to be a cell wall inhibitor that was once studied as an antiibacterial agent by Sankyo.

CAS 1075240-43-5 Omadacycline tosylate

Omadacycline tosylate
(CAS: 1075240-43-5)

Omadacycline tosylate is a new tetracycline antibiotic in the pipeline, which can inhibit the 30s subunit of bacterial ribosome.

CAS 179033-51-3 Timcodar

Timcodar
(CAS: 179033-51-3)

Timcodar, a pyridine derivative, has been found to be a p-glycoprotein inhibitor as well as nerve growth factor stimulant and was once studied in the treatment ...

CAS 186826-86-8 Moxifloxacin HCl

Moxifloxacin HCl
(CAS: 186826-86-8)

Moxifloxacin exerts its effects by trapping a DNA drug enzyme complex and specifically inhibiting ATP-dependent enzymes topoisomerase II (DNA gyrase) and topoisom...

CAS 120410-24-4 Biapenem

Biapenem
(CAS: 120410-24-4)

Biapenem (INN) is a carbapenem antibiotic. It has in vitro activity against anaerobes.

CAS 130-16-5 Cloxiquine

Cloxiquine
(CAS: 130-16-5)

Cloxiquine, a quinoline derivative, could be commonly used as anti-infective and antioxidant agent.

CAS 124858-35-1 Nadifloxacin

Nadifloxacin
(CAS: 124858-35-1)

Nadifloxacin is a potent, broad-spectrum, quinolone agent approved for topical use in acne vulgaris and skin infections.

CAS 1196800-40-4 Omadacycline mesylate

Omadacycline mesylate
(CAS: 1196800-40-4)

Omadacycline mesylate is a new tetracycline antibiotic in the pipeline, which can inhibit the 30s subunit of bacterial ribosome.

CAS 70458-95-6 Pefloxacin Mesylate

Pefloxacin Mesylate
(CAS: 70458-95-6)

Pefloxacin Mesylate is a synthetic chemotherapeutic agent and an antibacterial agent with IC50 of 6.7 nM.

CAS 119478-56-7 Meropenem trihydrate

Meropenem trihydrate
(CAS: 119478-56-7)

Meropenem (trihydrate) is a carbapenem antibiotic, which displaying a broad spectrum of antibacterial activity.

Chemical Structure

CAS 122841-10-5 Cefoselis

Quick Inquiry

Verification code

Featured Items